317 related articles for article (PubMed ID: 27555309)
41. Analysis of a phase-variable restriction modification system of the human gut symbiont Bacteroides fragilis.
Ben-Assa N; Coyne MJ; Fomenkov A; Livny J; Robins WP; Muniesa M; Carey V; Carasso S; Gefen T; Jofre J; Roberts RJ; Comstock LE; Geva-Zatorsky N
Nucleic Acids Res; 2020 Nov; 48(19):11040-11053. PubMed ID: 33045731
[TBL] [Abstract][Full Text] [Related]
42. Inactivation of MarR gene homologs increases susceptibility to antimicrobials in Bacteroides fragilis.
Silva CMG; Silva DNDS; Costa SBD; Almeida JSS; Boente RF; Teixeira FL; Domingues RMCP; Lobo LA
Braz J Microbiol; 2018; 49(1):200-206. PubMed ID: 28847541
[TBL] [Abstract][Full Text] [Related]
43. A proteolytically activated antimicrobial toxin encoded on a mobile plasmid of Bacteroidales induces a protective response.
Evans JC; McEneany VL; Coyne MJ; Caldwell EP; Sheahan ML; Von SS; Coyne EM; Tweten RK; Comstock LE
Nat Commun; 2022 Jul; 13(1):4258. PubMed ID: 35871068
[TBL] [Abstract][Full Text] [Related]
44. Virulence markers and antimicrobial susceptibility of bacteria of the Bacteroides fragilis group isolated from stool of children with diarrhea in São Paulo, Brazil.
Nakano V; Avila-Campos MJ
Mem Inst Oswaldo Cruz; 2004 May; 99(3):307-12. PubMed ID: 15273805
[TBL] [Abstract][Full Text] [Related]
45. The evolution of cooperation within the gut microbiota.
Rakoff-Nahoum S; Foster KR; Comstock LE
Nature; 2016 May; 533(7602):255-9. PubMed ID: 27111508
[TBL] [Abstract][Full Text] [Related]
46. Strain competition restricts colonization of an enteric pathogen and prevents colitis.
Hecht AL; Casterline BW; Earley ZM; Goo YA; Goodlett DR; Bubeck Wardenburg J
EMBO Rep; 2016 Sep; 17(9):1281-91. PubMed ID: 27432285
[TBL] [Abstract][Full Text] [Related]
47. Bacteroides uniformis CECT 7771 alleviates inflammation within the gut-adipose tissue axis involving TLR5 signaling in obese mice.
Fabersani E; Portune K; Campillo I; López-Almela I; la Paz SM; Romaní-Pérez M; Benítez-Páez A; Sanz Y
Sci Rep; 2021 Jun; 11(1):11788. PubMed ID: 34083551
[TBL] [Abstract][Full Text] [Related]
48. The occurrence of antibiotic resistance genes in drug resistant Bacteroides fragilis isolates from Groote Schuur Hospital, South Africa.
Meggersee R; Abratt V
Anaerobe; 2015 Apr; 32():1-6. PubMed ID: 25460195
[TBL] [Abstract][Full Text] [Related]
49. Efficient utilization of complex N-linked glycans is a selective advantage for Bacteroides fragilis in extraintestinal infections.
Cao Y; Rocha ER; Smith CJ
Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12901-6. PubMed ID: 25139987
[TBL] [Abstract][Full Text] [Related]
50. In vitro selection of ertapenem and piperacillin/tazobactam-resistant strains of Bacteroides fragilis and analysis of their virulence in gnotobiotic mice.
Valéria Dos Santos K; Roque DE Carvalho MA; Amancio Martins W; Coutinho SC; Bahia JL; Lopes DE Andrade JP; Morais Apolonio AC; Cara DC; Galuppo Diniz C; Nicoli JR; DE Macedo Farias L
J Chemother; 2010 Aug; 22(4):259-63. PubMed ID: 20685630
[TBL] [Abstract][Full Text] [Related]
51. beta-Lactamase produced by a highly beta-lactam-resistant strain of Bacteroides fragilis: an obstacle to the chemotherapy of experimental mixed infections.
Ajiki Y; Koga T; Ohya S; Takenouchi T; Yasuda H; Watanabe K; Ueno K
J Antimicrob Chemother; 1991 Oct; 28(4):537-46. PubMed ID: 1761449
[TBL] [Abstract][Full Text] [Related]
52. Pathogenicity of the Bacteroides fragilis group.
Brook I
Ann Clin Lab Sci; 1989; 19(5):360-76. PubMed ID: 2679351
[TBL] [Abstract][Full Text] [Related]
53. The Glycolytic Versatility of
Benítez-Páez A; Gómez Del Pulgar EM; Sanz Y
Front Cell Infect Microbiol; 2017; 7():383. PubMed ID: 28971068
[No Abstract] [Full Text] [Related]
54. The gut bacterium and pathobiont Bacteroides vulgatus activates NF-κB in a human gut epithelial cell line in a strain and growth phase dependent manner.
Ó Cuív P; de Wouters T; Giri R; Mondot S; Smith WJ; Blottière HM; Begun J; Morrison M
Anaerobe; 2017 Oct; 47():209-217. PubMed ID: 28583864
[TBL] [Abstract][Full Text] [Related]
55. Epidemiology of the Bacteroides fragilis group in the colonic flora in 10 patients with colonic cancer.
Namavar F; Theunissen EB; Verweij-Van Vught AM; Peerbooms PG; Bal M; Hoitsma HF; MacLaren DM
J Med Microbiol; 1989 Jul; 29(3):171-6. PubMed ID: 2746627
[TBL] [Abstract][Full Text] [Related]
56. Host Gut Motility Promotes Competitive Exclusion within a Model Intestinal Microbiota.
Wiles TJ; Jemielita M; Baker RP; Schlomann BH; Logan SL; Ganz J; Melancon E; Eisen JS; Guillemin K; Parthasarathy R
PLoS Biol; 2016 Jul; 14(7):e1002517. PubMed ID: 27458727
[TBL] [Abstract][Full Text] [Related]
57. Gnotobiotic mouse model of phage-bacterial host dynamics in the human gut.
Reyes A; Wu M; McNulty NP; Rohwer FL; Gordon JI
Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20236-41. PubMed ID: 24259713
[TBL] [Abstract][Full Text] [Related]
58. Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF.
Treviño M; Areses P; Peñalver MD; Cortizo S; Pardo F; del Molino ML; García-Riestra C; Hernández M; Llovo J; Regueiro BJ
Anaerobe; 2012 Feb; 18(1):37-43. PubMed ID: 22261518
[TBL] [Abstract][Full Text] [Related]
59. Human gut microbes use multiple transporters to distinguish vitamin B₁₂ analogs and compete in the gut.
Degnan PH; Barry NA; Mok KC; Taga ME; Goodman AL
Cell Host Microbe; 2014 Jan; 15(1):47-57. PubMed ID: 24439897
[TBL] [Abstract][Full Text] [Related]
60. Antimicrobial resistance in the Bacteroides fragilis group in faecal microbiota from healthy Danish children.
Sydenham TV; Jensen BH; Petersen AM; Krogfelt KA; Justesen US
Int J Antimicrob Agents; 2017 May; 49(5):573-578. PubMed ID: 28366659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
